-
A group of traditional Chinese medicine companies have achieved high growth in net profit!
Time of Update: 2022-08-30
Jiaying Pharmaceutical released its semi-annual performance report on the evening of August 19, saying that in the first half of this year, its operating income was about 247 million yuan, a year-on-year decrease of 2.
-
Accelerate innovation and transformation!
Time of Update: 2022-08-30
West China Securities also stated in the research report that Hengrui Medicine has increased investment in research and development, and many innovative drugs are in the early stage of high-speed volume, such as the company's fluzoparib, hetrombopag, remazolam, dalcili, and revelutamide.
-
Raised 3.2 billion!
Time of Update: 2022-08-30
2 billion yuan (including this amount), and after deducting the issuance costs, it is planned to be used to invest in the biopharmaceutical equipment industry trial production center project, Jiangsu Biomedical equipment industrialization base project, Zhejiang Tofflon Biotechnology Co.
-
Decoction pieces of traditional Chinese medicine are frequently "named", and digital transformation and upgrading need to be accelerated
Time of Update: 2022-08-30
For example, on August 17, the Anhui Provincial Food and Drug Administration issued an announcement saying that 7 companies of traditional Chinese medicine decoction pieces (including formula granules) had project defects, of which 5 companies rectified within a time limit, and 2 companies suspended production, warned and interviewed .
-
The pace of centralized dental implant collection is approaching, and many strands are affected
Time of Update: 2022-08-30
[Pharmaceutical Network Pharmaceutical Stock Market] On August 18, the National Medical Insurance Administration issued an announcement to solicit public opinions on the "Notice on the Special Treatment of Oral Implantation Medical Service Fees and Consumables Prices (Draft for Comment)" .
-
The time has come for the long-term layout of medicine, and the three main lines are worth paying attention to
Time of Update: 2022-08-30
The industry believes that with the rapid growth of innovative drug research and development and policy-driven, China's pharmaceutical outsourcing service (CXO) industry will usher in a period of rapid development in the future .
-
The wave of mergers and acquisitions in the pharmaceutical industry is surging, and the reasons are more diversified
Time of Update: 2022-08-30
According to relevant statistics, as of August 9, there have been 175 mergers and acquisitions in the domestic biopharmaceutical industry since the beginning of this year, with a total value of 48.
-
Under the continuous change of the pharmaceutical industry, the importance of independent control of the pharmaceutical industry chain is constantly highlighted
Time of Update: 2022-08-30
Therefore, the industry predicts that in the future, under the background of enterprises accelerating the construction of a complete industrial chain, it will continue to provide rare opportunities for the future development of China's pharmaceutical equipment industry.
-
A large number of children's drugs have been included in the priority review list!
Time of Update: 2022-08-30
In April this year, the product was included in the list of priority review varieties on the grounds of "new varieties, dosage forms and specifications of children's drugs that meet the physiological characteristics of children" .
-
The CRO market continues to expand, and the "involution" of local companies is also continuing to intensify
Time of Update: 2022-08-30
It is understood that as of now, among the CRO pharmaceutical companies that have disclosed their semi-annual reports, many of them have achieved outstanding performance, such as Asymchem, Proton, etc.
-
U.S. monkeypox vaccine shortage, people struggle to make appointments for vaccination
Time of Update: 2022-08-20
According to the US Centers for Disease Control and Prevention, the cumulative number of confirmed cases has exceeded 7,500 and has spread to 49 states in the United States .
-
Uniform coding rules and methods for pharmacy and technical personnel in designated medical institutions for medical insurance
Time of Update: 2022-08-20
Medical Security Bureau of all provinces, autonomous regions, municipalities directly under the Central Government and Xinjiang Production and Construction Corps: In order to accelerate the promotion
-
Newly confirmed cases of new coronary pneumonia in Japan and South Korea soar, the situation of epidemic prevention and control is grim
Time of Update: 2022-08-20
Japan's cumulative number of newly confirmed cases in 28 days ranks first in the world According to the Japan Broadcasting Association TV report, as of 18:00 local time on the 14th, there were 178,356 new confirmed cases of new coronary pneumonia and 153 new deaths in Japan in a single day .
-
Expert: The healthcare industry is in a critical period of digital transformation
Time of Update: 2022-08-20
(End) Disease Health Standard Chinese Medicine At the seminar on digital products and services for chronic disease prevention and treatment held this week, the participating experts believed that the medical and health industry is in a critical period of digital transformation, and the prospects for digital health technology and applications are very broad .
-
The pattern of Guangzhou dual-channel pharmacies is initially determined: 7 Guangzhou Pharmaceutical Departments
Time of Update: 2022-08-20
The list of the first batch of "dual-channel" pharmacies in Guangzhou was announced, involving a total of 30 retail pharmacies, including 7 from Guangzhou Pharmaceuticals, 4 from State Control, 4 fro
-
WHO: Monkeypox virus is spreading from person to person, don't stigmatize it
Time of Update: 2022-08-20
(Headquarters reporter Xue Jingmeng) On the 9th local time, at a regular press conference held at the United Nations Office in Geneva, World Health Organization spokesperson Margaret Harris pointed out that the monkeypox virus exists in several animals, mainly rodents .
-
More than 10,000 confirmed cases of monkeypox in the United States
Time of Update: 2022-08-20
According to data from the US Centers for Disease Control and Prevention, the United States reported 1,391 new confirmed cases of monkeypox on the 10th.
According to data from the US Centers for Disease Control and Prevention, the United States reported 1,391 new confirmed cases of monkeypox on the 10th.
-
Let the shortage of medicines not be in short supply!
Time of Update: 2022-08-20
Recently, the Ministry of Industry and Information Technology, the National Health Commission and other four departments jointly issued a notice to deploy and strengthen the monitoring of the production and reserve of drugs in short supply and the centralized procurement of drugs organized by the state .
-
From three perspectives, institutions are optimistic about the performance of pharmaceutical equipment in the field of medicine
Time of Update: 2022-08-19
At the same time, pharmaceutical equipment belongs to the field of high-end manufacturing, and some high-end pharmaceutical equipment has also been encouraged and supported by national policies in recent years, encouraging pharmaceutical machine companies to speed up the pace of domestic substitution .
-
Innovative drugs help a large number of pharmaceutical companies usher in new performance, but R&D investment will continue to increase
Time of Update: 2022-08-19
8% over the same period last year, and the proportion of innovative drug revenue has reached a record high of 62.
8% over the same period last year, and the proportion of innovative drug revenue has reached a record high of 62.
